Difficulty Concentrating or Paying Attention Mega Study
Contents
Difficulty Concentrating or Paying Attention
Difficulty Concentrating or Paying Attention

Related

A
1 to 5 Rating
A
Symptoms
A
Factors
A
Effects

Tags

Difficulty Concent Or Paying Attention
Paying Attention
Difficulty Concentrating
Difficulty Concentrating Or Paying Attention
Difficulty Concentrating Or Paying Attention

Treatments Causing Difficulty Concentrating or Paying Attention

User-reported treatments that exhibited the side effect of Difficulty Concentrating or Paying Attention

Treatment Percent of Reports
Neurontin 54%
Gabapentin (Neurontin) 54%

Below is the degree of change seen after Difficulty Concentrating or Paying Attention is higher than average.

Below is the change in Difficulty Concentrating or Paying Attention seen after the predictor is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.
Predictors
of
Below is the change in after the listed predictor is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change from the average seen after the predictor is higher than average.

Difficulty Concentrating or Paying Attention Info

Property Value
Variable Name Difficulty Concentrating Or Paying Attention
Aggregation Method MEAN
Analysis Performed At 2020-03-02
Duration of Action 24 hours
Maximum Allowed Value 5 out of 5
Minimum Allowed Value 1 out of 5
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 0
Number of Measurements 0
Number of Measurements (including those generated by tagged, joined, or child variables) 0
Public true
Onset Delay 0 seconds
Unit 1 to 5 Rating
User Variables 0
Variable Category Symptoms
Variable ID 87183